Purpose To investigate the difference in amide proton transfer (APT)-weighted signals between benign and atypical meningiomas and determine the value of APT imaging for differentiating the two. Methods Fifty-seven patients with pathologically diagnosed meningiomas (benign, 44; atypical, 13), who underwent preoperative MRI with APT imaging between December 2014 and August 2016 were included. We compared normalised magnetisation transfer ratio asymmetry (nMTR asym ) values between benign and atypical meningiomas on APT-weighted images. Conventional MRI features were qualitatively assessed. Both imaging features were evaluated by multivariable logistic regression analysis. The discriminative value of MRI with and without nMTR asym was evaluated. Results The nMTR asym of atypical meningiomas was significantly greater than that of benign meningiomas (2.46% vs.
Introduction
With advances in imaging techniques and knowledge of tumour microenvironment, chemical exchange saturation transfer (CEST) was proposed as a novel magnetic resonance imaging (MRI) technique for detecting endogenous mobile proteins and peptides, even at relatively low molecular concentrations [1] . Amide proton transfer (APT) imaging is a specific form of CEST imaging based on chemical exchange of amide protons without exogenous contrast agents [2] [3] [4] [5] . Here, exchangeable labile solute protons in amide bonds are selectively saturated by 3.5-ppm downfield off-resonance radiofrequency (RF) irradiation and transferred to bulk water by proton exchange, leading to a discernible decrease in signal intensity in bulk water and, eventually, to image contrast [4] . This technique has been successfully applied in human brain imaging for several diseases, including tumours and stroke [5] [6] [7] [8] [9] . Although the origin of APT signals in tumours is controversial, previous studies have suggested an increase in APT-weighted signals within brain tumours, especially in malignant tumours, due to increased mobile protein concentrations in malignant cells, associated with increased cellularity [2, 3, 5, 6, [9] [10] [11] .
Intracranial meningioma is a common primary brain tumour in adults [12, 13] . A majority of meningiomas are benign (World Health Organization [WHO] grade I) and have favourable prognosis. However, nearly 10% of meningiomas are atypical (WHO grade II) or malignant (WHO grade III) tumours with aggressive biological behaviour, a tendency to recur [14] , and, consequently, relatively worse prognosis, as evident from 5-year survival rates of 67.5% and 60% for patients with Grade II and III meningiomas, respectively [15] . In routine clinical practice, surgical resection followed by adjuvant radiotherapy is considered for treatment of atypical/ malignant meningioma, especially in cases involving subtotal resection [16] . Preoperative prediction of meningioma grade is important because it influences treatment planning, including the surgical resection strategy. For differentiating between benign and atypical/malignant meningiomas, several conventional MRI findings have been suggested as indicators of aggressive tumours, including non-skull base location, T2 hyperintensity, peritumoural brain oedema, indistinct tumour-brain interface, irregular tumour margins, heterogeneous tumour enhancement, capsular enhancement, cystic changes, and skull invasion [17] [18] [19] [20] [21] [22] [23] . These findings, however, are not sufficiently reliable for grading meningiomas to ensure proper treatment planning. Although several studies have investigated the feasibility of APT imaging for grading glial tumours [9, 24] , to the best of our knowledge, no study has employed APT imaging for grading meningiomas. Therefore, this study aimed to investigate the differences in APT-weighted signal between benign and atypical meningiomas and determine the value of APT imaging for differentiating the two.
Materials and methods

Study population
This retrospective study was approved by the institutional review board, and the requirement for informed consent was waived. Sixty consecutive patients with pathologically diagnosed meningiomas, who underwent preoperative MRI including APT and conventional imaging between December 2014 and August 2016, were enrolled. We excluded three patients because of poor image quality due to the susceptibility effect or patient motion (n = 2) and inadequate lesion size for image analysis (n = 1). Thus, 57 patients (male, 16; female, 41; mean age 54.4 ± 12.4 years) were included in this study. The interval between MRI and surgery was less than 3 days for all patients.
MRI protocol
Imaging studies were performed with a 3T MRI system (Achieva TX, Philips) using a 32-channel receiver head coil and a transmitter body coil. Conventional MR images were acquired according to the standard extra-axial brain tumour protocol in our hospital, which involves the following: (1) T2-weighted imaging (T2WI) in all three orthogonal directions; (2) axial T1-weighted imaging; and (3) threedimensional (3-D) contrast-enhanced T1WI. Additionally, APT images were acquired before contrast administration using the 3-D gradient-and spin-echo approach [25] with the following imaging parameters: acquisition voxel size, 2.2 x 2.2 mm; slice thickness, 4.4 mm; TR/TE, 3000/17 ms; turbo spin-echo factor, 22; echo planar imaging factor, 7; and number of slices to cover the entire tumour, 15. Six saturation frequency offsets (±3.0, ±3.5 and ±4.0 ppm) were adopted, with four repetitions at ±3.5 ppm, to attain sufficient signalto-noise ratio within the clinical time frame [5, 24] . Images were acquired with an RF saturation amplitude of 2 μT and total duration of 800 ms, with a four-block pulsed saturation scheme. Water-frequency shift due to field inhomogeneity was measured in a separate image acquired using the water-saturation shift referencing method with 21 offset frequencies ranging from -1.25 to 1.25 ppm, at intervals of 0.125 ppm (16 Hz) , with one reference image acquired without a saturation RF pulse, resulting in a full Z-spectrum within the offset range [26] . The water-saturation shift reference image was acquired with a TR/ TE of 1250/17 ms, RF saturation amplitude of 0.5 μT, and total duration of 400 ms, with a two-block pulsed saturation scheme. The total acquisition time for both APT and water-saturation shift reference images was 7 min 36 s.
APT image processing
After APT and water-saturation shift reference images were obtained, water frequency shift correction was performed. The full water-saturation shift Z-spectrum was fitted by a 12th order polynomial on voxel-by-voxel basis for all offset frequencies. The fitted curve was then interpolated at a higher spectral resolution (1 Hz), where the lowest signal in the fit after interpolation was assumed to be an actual water resonance frequency. The water centre frequency offset was set as the measured displacement between the actual and ideal the water resonance frequency (0 Hz). The acquired APTweighted data at the saturation frequency offsets (±3.0, ±3.5, ±4.0 ppm) were interpolated over the offset range and shifted using the estimated water centre frequency offset to obtain final shift-corrected APT-weighted image data [26] . Based on the shift-corrected data, magnetisation transfer ratio asymmetry (MTR asym ) values at ±3.5 ppm with respect to water frequency were calculated [4] :
where S 0 and S sat (±3.5 ppm) are MRI signals without and with saturation RF pulse, respectively. APTweighted images were then generated using MTR asym at 3.5 ppm. All data processing was performed offline, using Matlab (MathWorks, Natick, MA).
Image analysis
Circular regions of interest (ROIs) were drawn on APTweighted images, which were independently evaluated by two neuroradiologists (with 8 and 3 years of experience in neuroradiology) blinded to clinical and histopathological data. First, three circular ROIs were manually placed in different slices on raw APT images which exhibited similar contrast with T2WI for anatomical landmarks in the brain. Each ROI was located in a place that best represented the entire tumour signal. We carefully attempted to exclude cystic or necrotic portions referring to both T2WI and post-contrast T1WI and included the area with the highest signal within tumours. Another ROI was placed in normal-appearing white matter (NAWM). Then, the ROIs were transferred to processed APT-weighted images (Fig. 1) . The measured signal intensities in the three ROIs within tumour on processed APTweighted images were averaged to represent the tumour. Conventional MR images were analysed for tumour location, maximum tumour diameter, T2 hyperintensity, peritumoural brain oedema, irregular tumour margin, heterogeneous enhancement, capsular enhancement, cystic changes, hyperostosis of adjacent skull, skull invasion, and the dural tail sign by the same two neuroradiologists. Tumour location was categorized as Bskull base^or Bnon-skull base.^T2 hyperintensity was defined as higher signal intensity of the tumour relative to grey matter on T2WI. Irregular tumour margin was defined by the lobulated appearance of tumour margins on contrast-enhanced T1WI. The mean values of maximum tumour diameters measured by the two neuroradiologists were determined for further analysis. Discrepancies were settled by consensus between the two radiologists.
Surgery and pathological evaluation
All patients underwent surgical tumour resection after MRI. Pathological diagnosis was made by neuropathologists according to the WHO criteria. Criteria for atypical meningioma (WHO grade II) was 4 to 19 mitoses per 10 high-power fields (HPF), the presence of brain invasion, or the presence of at least three of these features ('sheet-like' growth, hypercellularity, spontaneous necrosis, large and prominent nucleoli, small cells), while criteria for malignant (anaplastic) meningioma (WHO grade III) was frank anaplasia (histology resembling carcinoma, sarcoma, or melanoma) or elevated mitoses with 20 or more mitoses per 10 HPF [27] [28] [29] . Additionally, the Ki-67 labelling index was evaluated in all patients. In 42 of 57 patients, mitotic count was evaluated using the mitotic marker phosphohistone-H3.
Statistical analysis
Based on the results of normality testing by the KolmogorovSmirnov test, MTR asym values were compared between enhancing tumours and NAWM by the paired t-test, and nMTR asym values and maximum tumour diameter were compared between patients with benign and atypical meningiomas by Student's t-test. Correlation between nMTR asym and the Ki-67 labelling index or mitotic count was evaluated by Pearson's correlation coefficient analysis.
Differences in frequencies of specific imaging features between benign and atypical meningiomas were determined by the chi-square or Fisher's exact test. Then, nMTR asym and conventional imaging features found to be significant in univariable analysis were further evaluated to compare the diagnostic performance by receiver operating characteristic (ROC) curve. To determine whether inclusion of nMTR asym with conventional MRI features improved the discriminative value of MRI for benign and atypical meningiomas, two different models comprising conventional imaging features, which were identified as being significantly associated with atypical meningioma based on univariable analysis with and without nMTR asym (models 1 and 2, respectively), were assessed based on the ROC curve using c-statistics (Harrell's concordance index) after multivariable logistic regression analyses. The net reclassification index (NRI) and integrated discrimination improvement (IDI) values of the two models were also calculated to evaluate the increase in discriminative value [30] .
Interobserver agreement on nMTR asym in APT images and maximum tumour size in conventional MR images was evaluated by intraclass correlation coefficients (ICC), while that on conventional imaging features was evaluated by Cohen's κ coefficient; ICC and κ values > 0.75 indicated excellent agreement. Statistical analyses were performed using SAS (version 9.2; SAS Institute Ind., Cary, NC, USA), MedCalc (version 9.3.6.0; MedCalc Software, Mariakerke, Belgium), and R (version 3.3.1; R Foundation for Statistical Computing, Vienna, Austria). Statistical significance was set at P < 0.05.
Results
Among the 57 included patients, 13 were pathologically diagnosed with atypical meningioma and 44 with benign meningioma (transitional, 18; meningothelial, 15; fibrous, eight; angiomatous, two; and secretory, one). None of the patients exhibited malignant meningiomas. While 39 patients exhibited non-skull base tumours (cerebral convexity, 19; parasagittal area, 18; and lateral ventricle, two), 18 exhibited skull base tumours (posterior fossa, eight; sphenoid ridge, five; parasellar, four; and anterior skull base, one). No patient showed tumour recurrence until February 2017.
There was a significant difference in MTR asym between enhancing tumours (1.84 ± 0.69%) and NAWM (0.10 ± 0.48%; P < 0.001). There was also a significant difference in nMTR asym between patients with benign and atypical meningiomas (1.67% vs. 2.46%; P < 0.001; Table 1 ). Figures 2 and 3 present representative cases of benign and atypical meningiomas, respectively. Atypical meningiomas exhibited higher APT-weighted signal intensities than benign meningiomas.
Both Ki-67 labelling index (3.25 ± 2.67) and mitotic count (2.45 ± 2.70) were significantly and positively correlated with nMTR asym (Pearson's correlation coefficients, 0.440 and 0.426, respectively; P = 0.002 and 0.017, respectively; Fig. 4 ).
The overall mean maximum tumour diameter was 46.4 ± 17.6 mm, with atypical meningiomas exhibiting significantly greater maximum tumour diameters than benign meningiomas (56.4 ± 23.1 vs. 43.4 ± 14.7 mm; P = 0.030). Heterogeneous enhancement and non-skull base location were observed significantly more often in atypical meningiomas than in benign meningiomas. There were no significant differences in the frequencies of other imaging features between the two tumours (Table 1) . ROC curve analysis with nMTR asym , heterogeneous enhancement, maximum tumour diameter, and non-skull base location, the nMTR asym showed significantly higher area under the curve (AUC) value than the others. The optimal cut-off value of nMTR asym for predicting atypical meningiomas was >2. 19 On multivariable logistic regression analysis of the four variables, nMTR asym was an independent imaging biomarker for predicting atypical meningioma (odds ratio, 11.227; P = 0.014; Table 2 ). On comparison of the predictive power for atypical meningioma of the two multivariable models (model 1 with covariates as maximum tumour diameter, heterogeneous enhancement, and non-skull base location; model 2 with covariates as maximum tumour diameter, heterogeneous enhancement, non-skull base location, and nMTR asym ) using c-statistics analysis, model 2 exhibited a significantly better diagnostic performance than model 1 (AUC: 0.879 vs. 0.764; P = 0.039). Model 2 also exhibited better performance with Fig. 3 A 57-year-old female patient with atypical meningioma exhibiting intermediate signal intensity on a T2-weighted image (a) and homogeneous enhancement on a contrastenhanced T1-weighted image (b). A ROI was drawn on area which showed the highest signal within the tumour on a raw APT image (c) and then transferred to the processed APT-weighted image (d). The normalised magnetisation transfer ratio asymmetry value within the enhancing tumour was 3.12 (c) (Table 2) .
Interobserver agreement on nMTR asym and maximum tu- 
Discussion
Although surgical resection is the main treatment for meningiomas, monitoring or gamma-knife surgery is considered in patients with asymptomatic small meningiomas without pathological diagnosis [31] . Therefore, it is important to identify atypical meningiomas preoperatively. In the present study, we investigated the ability of APT imaging to differentiate between benign and atypical meningiomas. Although preliminary studies have employed APT imaging for evaluation of brain tumours [6, 32] , to the best of our knowledge, the present results are the first to describe the feasibility of APT imaging for grading meningiomas. The MTR asym values of both tumours and normal brain tissue are affected by various tissue microenvironment and technical factors. Therefore, we evaluated the diagnostic value of APT imaging based on nMTR asym -the difference in MTR asym between tumours and normal brain tissue-because it is minimally affected by non-physiologic factors. Atypical meningiomas exhibited significantly higher nMTR asym than benign meningiomas (2.46% vs. 1.67%), which is in accordance with results of previous studies on APT imaging for grading gliomas that also reported significant increases in signal intensity according to tumour grade [9, 24] .
Among the conventional MR features evaluated in the present study, greater maximum tumour diameter, heterogeneous enhancement, and non-skull base location were associated with atypical meningiomas. A recent study also reported the association between tumour volume and histopathological grade of meningioma, which may be attributed to the relatively high proliferative potential of high-grade tumours [18] . Heterogeneous enhancement is associated with heterogeneous distribution of tumour cells, which reflects intratumoural ischemic necrosis, calcification, haemorrhage, and/or cystic changes [18] [19] [20] . We also found that non-skull base meningiomas were more likely to be atypical meningiomas, which is in line with previous findings [21] [22] [23] . Furthermore, previous studies have reported the association of anatomical location of Model 1 = maximum tumour diameter + heterogeneous enhancement + non-skull base location Model 2 = maximum tumour diameter + heterogeneous enhancement + non-skull base location + nMTR asym AUC = area under the receiver operating characteristic curve, CI = confidence interval, IDI = integrated discrimination index, nMTR asym = normalised magnetisation transfer ratio asymmetry value, NRI = net reclassification index, OR = odds ratio.
*P = 0.039 meningiomas with not only WHO classification but also higher MIB-1 and Ki-67 labelling indexes [22, 33] . In the present study, however, APT imaging exhibited a better diagnostic performance than conventional MRI in diagnosis of atypical meningiomas. The results of multivariable regression analysis with conventional MRI features and nMTR asym as covariates revealed only high nMTR asym as being a statistically significant predictor of atypical meningiomas. Inclusion of APT imaging parameters with conventional imaging features improved the discriminative value of MRI for benign and atypical meningiomas. Considering that it is relatively difficult to demonstrate a significant difference in AUC analysis of performance models despite an added biomarker being a clinically significant factor, our results indicate the superior discriminative ability of APT imaging for benign and atypical meningiomas. The diagnostic improvement in MRI upon inclusion of APT imaging was also validated by NRI and IDI, which exhibited values greater than zero.
Recent studies on gliomas have demonstrated the positive correlation of APT-weighted signal intensity with Ki-67 labelling and cell proliferation index [9, 10] . In the present study, we also found that APT-weighted signal intensity is positively correlated to Ki-67 labelling index and mitotic count. These results might reflect that high-grade tumours, which exhibit higher proliferative and mitotic activities, have higher densities of cells and, hence, higher concentrations of intracellular proteins and peptides than low-grade tumours.
There are several limitations to the present study. First, there are several previous studies attempting to differentiate typical and atypical/malignant meningiomas by means of diffusion-weighted imaging, which have reported contradictory results [17, 18, 34] . In addition, there are previous studies investigating perfusion MRI in meningioma patients, which reported perfusion MRI findings were correlated with grade of meningioma or Ki-67 labelling index in meningioma [35, 36] . Further studies are required to compare the diagnostic performances of diffusion-weighted imaging, perfusion MRI, and APT imaging in differentiating benign and atypical meningiomas. Second, instead of segmenting entire tumours, ROIs were placed manually in the solid portions of tumours which we thought represented tumour characteristics the most. We chose this method because meningiomas occur near the skull, which is susceptible to field inhomogeneity and consequently may affect APT signals. In addition, the resolution of APT imaging must be improved to achieve adequate coregistration with conventional MRI images and segmentation of the entire tumour. Third, because pathological specimens lose location information during surgical resection, there might have been mismatches between ROIs on images and pathological specimens from resection. Lastly, there were various subtypes of benign meningioma in this study, which might require further investigation to clarify the relation between each subgroup and diagnostic performance. On the other hand, there was a limited number of atypical meningioma patients and lack of malignant meningioma patients. However, considering the relative rarity of these types of tumours, this result was inevitable.
In summary, atypical meningiomas exhibited significantly higher APT-weighted signal intensities than benign meningiomas. Therefore, APT imaging is a useful imaging biomarker that adds value to conventional MRI for differentiation of atypical and benign meningiomas.
